{"pmid":32362384,"pmcid":"PMC7193137","title":"SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection.","text":["SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection.","This consensus document has been drawn up by the Techniques and Transplantation and Nursing areas of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Respiratory Endoscopy (AEER) with the aim of providing information on the safe and effective use of bronchoscopy in patients with suspected or confirmed COVID-19 infection. Our priority is to ensure the safety of our patients, the health workers caring for them, and the community in general. At this stage in the pandemic, our information on the use of bronchoscopy in patients of this type is based on the experience of hospitals in other countries, and scientific publications are scarce. The objective of this document is to compile these experiences, based on recommendations from official agencies, in a document offering guidance in daily clinical practice.","Arch Bronconeumol","Cordovilla, Rosa","Alvarez, Susana","Llanos, Liliana","Nunez Ares, Ana","Cases Viedma, Enrique","Diaz-Perez, David","Flandes, Javier","32362384"],"abstract":["This consensus document has been drawn up by the Techniques and Transplantation and Nursing areas of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Respiratory Endoscopy (AEER) with the aim of providing information on the safe and effective use of bronchoscopy in patients with suspected or confirmed COVID-19 infection. Our priority is to ensure the safety of our patients, the health workers caring for them, and the community in general. At this stage in the pandemic, our information on the use of bronchoscopy in patients of this type is based on the experience of hospitals in other countries, and scientific publications are scarce. The objective of this document is to compile these experiences, based on recommendations from official agencies, in a document offering guidance in daily clinical practice."],"journal":"Arch Bronconeumol","authors":["Cordovilla, Rosa","Alvarez, Susana","Llanos, Liliana","Nunez Ares, Ana","Cases Viedma, Enrique","Diaz-Perez, David","Flandes, Javier"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362384","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.arbres.2020.03.017","keywords":["bronchoscopy","broncoscopia","covid-19","consenso","consensus"],"topics":["Prevention"],"weight":1,"_version_":1666138496080805889,"score":9.490897,"similar":[{"pmid":32307151,"pmcid":"PMC7161530","title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Rev Esp Anestesiol Reanim","Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C","32307151"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Rev Esp Anestesiol Reanim","authors":["Cinesi Gomez, C","Penuelas Rodriguez, O","Lujan Torne, M L","Egea Santaolalla, C","Masa Jimenez, J F","Garcia Fernandez, J","Carratala Perales, J M","Heili-Frades, S B","Ferrer Monreal, M","de Andres Nilsson, J M","Lista Arias, E","Sanchez Rocamora, J L","Garrote, J I","Zamorano Serrano, M J","Gonzalez Martinez, M","Farrero Munoz, E","Mediano San Andres, O","Rialp Cervera, G","Mas Serra, A","Hernandez Martinez, G","de Haro Lopez, C","Roca Gas, O","Ferrer Roca, R","Romero Berrocal, A","Ferrando Ortola, C"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307151","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.redar.2020.03.006","keywords":["aerosol-generating procedures","control de infeccion.","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138491176615936,"score":250.31807},{"pmid":32312600,"title":"Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","text":["Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Med Intensiva","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32312600"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Med Intensiva","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312600","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.medin.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138493449928705,"score":250.31807},{"pmid":32336563,"title":"Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","text":["Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection.","Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.","Arch Bronconeumol","Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos","32336563"],"abstract":["Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials."],"journal":"Arch Bronconeumol","authors":["Cinesi Gomez, Cesar","Penuelas Rodriguez, Oscar","Lujan Torne, Manel","Egea Santaolalla, Carlos","Masa Jimenez, Juan Fernando","Garcia Fernandez, Javier","Carratala Perales, Jose Manuel","Heili-Frades, Sarah Beatrice","Ferrer Monreal, Miquel","de Andres Nilsson, Jose M","Lista Arias, Eva","Sanchez Rocamora, Juan Luis","Garrote, Jose Ignacio","Zamorano Serrano, Miguel J","Gonzalez Martinez, Monica","Farrero Munoz, Eva","Mediano San Andres, Olga","Rialp Cervera, Gemma","Mas Serra, Arantxa","Hernandez Martinez, Gonzalo","de Haro Lopez, Candelaria","Roca Gas, Oriol","Ferrer Roca, Ricard","Romero Berrocal, Antonio","Ferrando Ortola, Carlos"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336563","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.arbres.2020.03.005","keywords":["aerosol-generating procedures","control de infeccion","high-flow nasal therapy","infection control","non-invasive mechanical ventilation","procedimientos generadores de aerosoles","terapia nasal de alto flujo","ventilacion mecanica no invasiva"],"locations":["Wuhan","China","multiorgan","Spanish","Spanish","Spanish","Spanish","Spanish"],"countries":["China","Spain"],"countries_codes":["CHN|China","ESP|Spain"],"topics":["Treatment"],"weight":1,"_version_":1666138494176591872,"score":250.31807},{"pmid":32361152,"title":"The Use of Bronchoscopy during the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report.","text":["The Use of Bronchoscopy during the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report.","BACKGROUND: The coronavirus disease 2019 (COVID-19) has swept the globe and is causing significant morbidity and mortality. Given that the virus is transmitted via droplets, open airway procedures such as bronchoscopy pose a significant risk to health care workers (HCW). The goal of this guideline was to examine the current evidence on the role of bronchoscopy during the COVID-19 pandemic and the optimal protection of patients and HCW. METHODS: A group of approved panelists developed key clinical questions by using the PICO (population, intervention, comparator, and outcome) format that addressed specific topics on bronchoscopy related to COVID-19 infection and transmission. MEDLINE (via PubMed) was systematically searched for relevant literature and references were screened for inclusion. Validated evaluation tools were used to assess the quality of studies and to grade the level of evidence to support each recommendation. When evidence did not exist, suggestions were developed based on consensus using the modified Delphi process RESULTS: The systematic review and critical analysis of the literature based on six PICO questions resulted in six statements: one evidence-based graded recommendation and 5 ungraded consensus-based statements. CONCLUSIONS: The evidence on the role of bronchoscopy during the COVID-19 pandemic is sparse. To maximize protection of patients and HCW, bronchoscopy should be used sparingly in the evaluation and management of patients with suspected or confirmed COVID-19 infections. In an area where community transmission of COVID-19 infection is present, bronchoscopy should be deferred for non-urgent indications and, if necessary to perform, HCW should wear personal protective equipment while performing the procedure even on asymptomatic patients.","Chest","Wahidi, Momen M","Shojaee, Samira","Lamb, Carla R","Ost, David","Maldonado, Fabien","Eapen, George","Caroff, Daniel A","Stevens, Michael P","Ouellette, Daniel R","Lilly, Craig","Gardner, Donna D","Glisinski, Kristen","Pennington, Kelly","Alalawi, Raed","32361152"],"abstract":["BACKGROUND: The coronavirus disease 2019 (COVID-19) has swept the globe and is causing significant morbidity and mortality. Given that the virus is transmitted via droplets, open airway procedures such as bronchoscopy pose a significant risk to health care workers (HCW). The goal of this guideline was to examine the current evidence on the role of bronchoscopy during the COVID-19 pandemic and the optimal protection of patients and HCW. METHODS: A group of approved panelists developed key clinical questions by using the PICO (population, intervention, comparator, and outcome) format that addressed specific topics on bronchoscopy related to COVID-19 infection and transmission. MEDLINE (via PubMed) was systematically searched for relevant literature and references were screened for inclusion. Validated evaluation tools were used to assess the quality of studies and to grade the level of evidence to support each recommendation. When evidence did not exist, suggestions were developed based on consensus using the modified Delphi process RESULTS: The systematic review and critical analysis of the literature based on six PICO questions resulted in six statements: one evidence-based graded recommendation and 5 ungraded consensus-based statements. CONCLUSIONS: The evidence on the role of bronchoscopy during the COVID-19 pandemic is sparse. To maximize protection of patients and HCW, bronchoscopy should be used sparingly in the evaluation and management of patients with suspected or confirmed COVID-19 infections. In an area where community transmission of COVID-19 infection is present, bronchoscopy should be deferred for non-urgent indications and, if necessary to perform, HCW should wear personal protective equipment while performing the procedure even on asymptomatic patients."],"journal":"Chest","authors":["Wahidi, Momen M","Shojaee, Samira","Lamb, Carla R","Ost, David","Maldonado, Fabien","Eapen, George","Caroff, Daniel A","Stevens, Michael P","Ouellette, Daniel R","Lilly, Craig","Gardner, Donna D","Glisinski, Kristen","Pennington, Kelly","Alalawi, Raed"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32361152","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.chest.2020.04.036","keywords":["bronchoscopy","covid-19"],"topics":["Prevention"],"weight":1,"_version_":1666138495565955073,"score":242.50653},{"pmid":32336564,"pmcid":"PMC7130643","title":"SEPAR-AEER Consensus Recommendations on the Usefulness of the Thoracic Ultrasound in the Management of the Patient with Suspected or Confirmed Infection with COVID-19.","text":["SEPAR-AEER Consensus Recommendations on the Usefulness of the Thoracic Ultrasound in the Management of the Patient with Suspected or Confirmed Infection with COVID-19.","The great pulmonary affectation produced by the COVID-19 infection, requires a fast diagnostic tool that complements the diagnostic test by PCR and which is also useful in evaluating the progression of lung lesions. Since most of these are peripheral, in this consensus document we propose the use of thoracic ultrasound for early diagnosis and for the daily evaluation of the progression of lung lesions by a single explorer without the need to use the chest CT. In this consensus, it is proposed to carry out a systematic ultrasound examination of the thorax dividing it by quadrants and therefore identifying the ultrasound signs that are related to the type of parenchymal or pleural affectation that the patient has: A lines, B lines, parenchymal condensation, pleural line and pleural effusion. These findings will facilitate the decision making regarding the patient management, both when deciding the place of admission of the patient and the type of treatment to be prescribed.","Arch Bronconeumol","Perez Pallares, Javier","Flandes Aldeyturriaga, Javier","Cases Viedma, Enrique","Cordovilla Perez, Rosa","32336564"],"abstract":["The great pulmonary affectation produced by the COVID-19 infection, requires a fast diagnostic tool that complements the diagnostic test by PCR and which is also useful in evaluating the progression of lung lesions. Since most of these are peripheral, in this consensus document we propose the use of thoracic ultrasound for early diagnosis and for the daily evaluation of the progression of lung lesions by a single explorer without the need to use the chest CT. In this consensus, it is proposed to carry out a systematic ultrasound examination of the thorax dividing it by quadrants and therefore identifying the ultrasound signs that are related to the type of parenchymal or pleural affectation that the patient has: A lines, B lines, parenchymal condensation, pleural line and pleural effusion. These findings will facilitate the decision making regarding the patient management, both when deciding the place of admission of the patient and the type of treatment to be prescribed."],"journal":"Arch Bronconeumol","authors":["Perez Pallares, Javier","Flandes Aldeyturriaga, Javier","Cases Viedma, Enrique","Cordovilla Perez, Rosa"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336564","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.arbres.2020.03.019","keywords":["b-lines","coronavirus","derrame pleural","ecografia","lineas-b","neumonia","pleura","pleural effussion","pneumonia","ultrasound"],"locations":["thoracic","SEPAR"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138494299275264,"score":235.5834}]}